Trial intelligence / Profile preview

Opioid-free tubeless anesthesia with esketamine in thoracoscopic lung surgery

ChiCTR2300073768Phase 4Recruiting

Sponsor
The Affiliated Hospital of Yangzhou University
Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of esketamine (2 arms), sponsored by The Affiliated Hospital of Yangzhou University. Primary endpoints: Arterial blood gas values, Inflammatory factors and 1 more. Started Jan 2023; status: recruiting.

02

Drugs

esketamine

Beyond the preview

Go deeper on ChiCTR2300073768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300073768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call